Peter Craddock
Peter spent over twelve years with Kidder, Peabody and DLJ, most recently as a vice president in the corporate services division. During that time he assisted in originating investment banking transactions in the public and private markets with companies such as Qwest Communications International, Somatogen, IVAC Medical Systems (now Alaris), Spectranetics, IMSI, Triad and others.
Since 1989, he has been, individually and through SVP I and II, an early stage investor in numerous successful seed and early stage companies, including CV Therapeutics (CVTX), Chili!Soft, Speedchain Networks, ARYx Therapeutics, Lifeline Technologies, Overread, Hall-Kinion (HAKI), Cambric, Z-force (now Attune Systems) and others.
Peter has also served on numerous boards including Aryx Therapeutics, Speedchain Networks, IntelliDOT Corporation, Navitas Cancer Rehabilitation Centers and as a board observer for a number of other companies including Health Hero Networks and CV Therapeutics. He is focused on opportunities in the health care and IT sectors.
Leave a Reply